Real-world outcomes of patients with human epidermal growth factor 2 (HER2)-positive breast cancer receiving neoadjuvant therapy without adjuvant ado-trastuzumab emtansine (T-DM1).
Ado-Trastuzumab Emtansine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Real-world outcomes of patients with human epidermal growth factor 2 (HER2)-positive breast cancer receiving neoadjuvant therapy without adjuvant ado-trastuzumab emtansine (T-DM1). ### Output: Ado-Trastuzumab Emtansine